Laddar...
Real-World Evidence of Patient Outcome Following Treatment of Advanced Gastrointestinal Stromal Tumor (GIST) with Imatinib, Sunitinib, and Sorafenib in Publicly Funded Health Care in Poland
BACKGROUND: This study aimed to undertake an analysis of ten years of real-world evidence (RWE) on overall survival (OS) following treatment of advanced gastrointestinal stromal tumor (GIST) with imatinib, sunitinib, and sorafenib using data from the Polish National Health Fund. MATERIAL/METHODS: Da...
Sparad:
| I publikationen: | Med Sci Monit |
|---|---|
| Huvudupphovsmän: | , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
International Scientific Literature, Inc.
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6543874/ https://ncbi.nlm.nih.gov/pubmed/31121600 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.914517 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|